Food allergy diagnosis and therapy: where are we now?

被引：10

作者：

Syed, Aleena ^{[1
]}

Kohli, Arunima ^{[1
]}

Nadeau, Kari C. ^{[1
]}

机构：

[1] Stanford Univ, Dept Pediat, Sch Med, Div Rheumatol Allergy & Immunol, Stanford, CA 94305 USA

来源：

IMMUNOTHERAPY | 2013年 / 5卷 / 09期

关键词：

allergy diagnosis; food allergy; immunotherapy; oral immunotherapy; PEANUT ORAL IMMUNOTHERAPY; INFANT GUT MICROBIOTA; E-BINDING EPITOPES; COWS MILK ALLERGY; PRU P 3; T-CELL; DOUBLE-BLIND; SUBLINGUAL IMMUNOTHERAPY; EGG ALLERGY; EPICUTANEOUS IMMUNOTHERAPY;

D O I：

10.2217/imt.13.93

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Food allergy is a growing worldwide epidemic that adversely effects up to 10% of the population. Causes and risk factors remain unclear and diagnostic methods are imprecise. There is currently no accepted treatment for food allergy. Therefore, there is an imminent need for greater understanding of food allergies, revised diagnostics and development of safe, effective therapies. Oral immunotherapy provides a particularly promising avenue, but is still highly experimental and not ready for clinical use.

引用

页码：931 / 944

页数：14

共 50 条

[21] Monitoring antiplatelet therapy: where are we now?
Marcucci, Rossella
Berteotti, Martina
Gragnano, Felice
Galli, Mattia
Cavallari, Ilaria
Renda, Giulia
Capranzano, Piera
Santilli, Francesca
Capodanno, Davide J.
Angiolillo, Dominick
Cirillo, Plinio
Calabro, Paolo
Patti, Giuseppe
De Caterina, Raffaele
Working Grp Thrombosis
Italian Soc Cardiology
JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 : E24 - E35
[22] Where are we now with hormone replacement therapy?
McPherson, U
REPRODUCTIVE HEALTH MATTERS, 2004, 12 (24) : 200 - 203
[23] GENE THERAPY IN HAEMOPHILIA: WHERE ARE WE NOW?
Pierce, G. F.
HAEMOPHILIA, 2021, 27 : 14 - 14
[24] Behavior therapy for obesity: where are we now?
Sarwer, David B.
Green, Amy von Sydow
Vetter, Marion L.
Wadden, Thomas A.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (05) : 347 - 352
[25] Combination therapy in dyslipidemia: Where are we now?
Catapano, Alberico L.
Farnier, Michel
Foody, JoAnne M.
Toth, Peter P.
Tomassini, Joanne E.
Brudi, Philippe
Tershakovec, Andrew M.
ATHEROSCLEROSIS, 2014, 237 (01) : 319 - 335
[26] Therapy outcome measures: Where are we now?
John, Alexandra
INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2011, 13 (01) : 36 - 42
[27] Neoadjuvant Therapy in Melanoma: Where Are We Now?
Saad, Mariam
Tarhini, Ahmad A.
CURRENT ONCOLOGY REPORTS, 2023, 25 (04) : 325 - 339
[28] Occupational therapy awareness: Where are we now?
Kingsland, Nancy
Wilson, Angela
INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2008, 15 (01): : 6 - 6
[29] Neoadjuvant Therapy in Melanoma: Where Are We Now?
Mariam Saad
Ahmad A. Tarhini
Current Oncology Reports, 2023, 25 : 325 - 339
[30] Hormone replacement therapy - where are we now?
Langer, R. D.
Hodis, H. N.
Lobo, R. A.
Allison, M. A.
CLIMACTERIC, 2021, 24 (01) : 3 - 10

← 1 2 3 4 5 →